World's Largest Resource for Cardiovascular Perfusion

+1 888-499-5672 Login

WebCast ! Hemetech’s Perfusion Basic Science Review: January 2015

Circuit Surfers, Perfusion.com

Click image to view meeting details

Sat Jan 31, Sun Feb 1, 2015

Webcast LIVE Online

weblink to be provided prior to event

Perfusion Basic Science Review

CEU’s:

CEUs to be applied for (expect 20.1 Category 1 and 8.8 SDCEs)

Registration:

To register: [email protected] or 740-396-8787

About Hemetech

The Course

Saturday morning through Sunday afternoon:

Our Basic Science Review includes:

Anatomy / Physiology, Embryology,
Congenital Cardiac Defects,
Pathophysiology,
Instrumentation / Analysis,
Perfusion Safety,
ECC Devices,
Adequacy of Perfusion,
Conduct of Bypass,
Pharmacology,
Blood Conservation, Myocardial
Preservation,
Special Considerations,
IABP, Study Techniques,
A Practice examination with a review

VENUE:

Your Home Computer !

Frank Aprile

Leave a Reply Cancel reply

You must be logged in to post a comment.

You may also like

Main Zone, Mobile Zone, Perfusion Zone

Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis who are at High Risk for Surgical Complications: Summary Assessment of the California Technology Assessment Forum

TAVR is a potentially lifesaving procedure that may improve quality of life for patients at high risk for surgical AVR.

Main Zone, Mobile Zone

Interventions to Reduce Major Vascular Complications of TAVR

The aim of the present review is to review some of the recent developments and techniques, which have resulted in a reduction in the risk of vascular complications during transfemoral transcatheter aortic valve replacement.

Main Zone, Mobile Zone, Perfusion Zone

β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial

This study evaluates whether β-blockers were associated with a reduction in cardiovascular events or angina after Coronary Artery Bypass Graft (CABG) surgery, in otherwise stable low-risk patients during a mid-term follow-up.